Clinical Trials
SPINAL CORD INJURY
A safety trial of a human spinal cord-derived neural stem cell line in people with paralysis due to a spinal cord injury.
TYPE 1 DIABETES
A Phase I/II clinical trial of a combination product to treat people with type 1 diabetes and hypoglycemia unawareness.
LEUKEMIA
A clinical trial to evaluate the effectiveness of the ROR1-targeting monoclonal antibody, cirmtuzumab, when given in combination with a BTK inhibitor, ibrutinib, in people with chronic lymphocytic leukemia, small lymphocytic leukemia or mantle cell lymphoma.
CHRONIC HEART FAILURE
A Phase III clinical trial of bone marrow-derived mesenchymal precursor cell transplantation in people with chronic heart failure due to LV systolic dysfunction.
Shared Research Cores
Molecular Imaging Center
Advances state-of-the-art in vivo preclinical imaging and spectroscopy techniques to better understand tissue and organ function, and to make these tools available to the greater biomedical research community
STEM CELL GENOMICS CORE
A self-service and full-service genomics facility offering state of the art equipment and cutting edge technology
HUMAN EMBRYONIC STEM CELL CORE FACILITY
Provides tissue culture space and access to high end cell characterization equipment including cell sorter, MEA, and microscopy
SANFORD STEM CELL INSTITUTE (SSCI) is a global leader in regenerative medicine and hub for stem cell science and innovation in space. SSCI aims to catalyze critical basic research discoveries, translational advances, and clinical progress terrestrially and in space to develop and deliver novel therapeutics to patients.